Characterization of Exome Variants and Their Metabolic Impact in 6,716 American Indians from the Southwest US
Tài liệu tham khảo
Lim, 2014, Distribution and medical impact of loss-of-function variants in the Finnish founder population, PLoS Genet., 10, e1004494, 10.1371/journal.pgen.1004494
Southam, 2017, Whole genome sequencing and imputation in isolated populations identify genetic associations with medically-relevant complex traits, Nat. Commun., 8, 15606, 10.1038/ncomms15606
Xue, 2017, Enrichment of low-frequency functional variants revealed by whole-genome sequencing of multiple isolated European populations, Nat. Commun., 8, 15927, 10.1038/ncomms15927
Rivas, 2018, Insights into the genetic epidemiology of Crohn’s and rare diseases in the Ashkenazi Jewish population, PLoS Genet., 14, e1007329, 10.1371/journal.pgen.1007329
Locke, 2019, Exome sequencing of Finnish isolates enhances rare-variant association power, Nature, 572, 323, 10.1038/s41586-019-1457-z
Hou, 2017, A population-specific reference panel empowers genetic studies of Anabaptist populations, Sci. Rep., 7, 6079, 10.1038/s41598-017-05445-3
Sidore, 2015, Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers, Nat. Genet., 47, 1272, 10.1038/ng.3368
Kitchen, 2008, A three-stage colonization model for the peopling of the Americas, PLoS ONE, 3, e1596, 10.1371/journal.pone.0001596
O’Fallon, 2011, Native Americans experienced a strong population bottleneck coincident with European contact, Proc. Natl. Acad. Sci. USA, 108, 20444, 10.1073/pnas.1112563108
Ma, 2012, Principal components analysis of population admixture, PLoS ONE, 7, e40115, 10.1371/journal.pone.0040115
Verdu, 2014, Patterns of admixture and population structure in native populations of Northwest North America, PLoS Genet., 10, e1004530, 10.1371/journal.pgen.1004530
Bennett, 1971, Diabetes mellitus in American (Pima) Indians, Lancet, 2, 125, 10.1016/S0140-6736(71)92303-8
Knowler, 1978, Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota, Am. J. Epidemiol., 108, 497, 10.1093/oxfordjournals.aje.a112648
Knowler, 1990, Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis, Diabetes Metab. Rev., 6, 1, 10.1002/dmr.5610060101
Hsueh, 2017, Identity-by-Descent Mapping Identifies Major Locus for Serum Triglycerides in Amerindians Largely Explained by an APOC3 Founder Mutation, Circ Cardiovasc Genet, 10, e001809, 10.1161/CIRCGENETICS.117.001809
Hanson, 2007, A search for variants associated with young-onset type 2 diabetes in American Indians in a 100K genotyping array, Diabetes, 56, 3045, 10.2337/db07-0462
Hanson, 2014, A genome-wide association study in American Indians implicates DNER as a susceptibility locus for type 2 diabetes, Diabetes, 63, 369, 10.2337/db13-0416
Malhotra, 2011, A genome-wide association study of BMI in American Indians, Obesity (Silver Spring), 19, 2102, 10.1038/oby.2011.178
Bian, 2013, MAP2K3 is associated with body mass index in American Indians and Caucasians and may mediate hypothalamic inflammation, Hum. Mol. Genet., 22, 4438, 10.1093/hmg/ddt291
Piaggi, 2017, A Genome-Wide Association Study Using a Custom Genotyping Array Identifies Variants in GPR158 Associated With Reduced Energy Expenditure in American Indians, Diabetes, 66, 2284, 10.2337/db16-1565
Hanson, 2013, Strong parent-of-origin effects in the association of KCNQ1 variants with type 2 diabetes in American Indians, Diabetes, 62, 2984, 10.2337/db12-1767
Hanson, 2015, Role of Established Type 2 Diabetes-Susceptibility Genetic Variants in a High Prevalence American Indian Population, Diabetes, 64, 2646, 10.2337/db14-1715
Muller, 2019, Assessing the Role of 98 Established Loci for BMI in American Indians, Obesity (Silver Spring), 27, 845, 10.1002/oby.22433
Muller, 2017, Assessing variation across 8 established East Asian loci for type 2 diabetes mellitus in American Indians: Suggestive evidence for new sex-specific diabetes signals in GLIS3 and ZFAND3, Diabetes Metab. Res. Rev., 33, 10.1002/dmrr.2869
Nair, 2014, Variants associated with type 2 diabetes identified by the transethnic meta-analysis study: assessment in American Indians and evidence for a new signal in LPP, Diabetologia, 57, 2334, 10.1007/s00125-014-3351-4
Nair, 2016, Assessment of established HDL-C loci for association with HDL-C levels and type 2 diabetes in Pima Indians, Diabetologia, 59, 481, 10.1007/s00125-015-3835-x
Thearle, 2012, Greater impact of melanocortin-4 receptor deficiency on rates of growth and risk of type 2 diabetes during childhood compared with adulthood in Pima Indians, Diabetes, 61, 250, 10.2337/db11-0708
Traurig, 2012, Variants in the LEPR gene are nominally associated with higher BMI and lower 24-h energy expenditure in Pima Indians, Obesity (Silver Spring), 20, 2426, 10.1038/oby.2012.159
Muller, 2014, Common genetic variation in the glucokinase gene (GCK) is associated with type 2 diabetes and rates of carbohydrate oxidation and energy expenditure, Diabetologia, 57, 1382, 10.1007/s00125-014-3234-8
Baier, 2015, ABCC8 R1420H Loss-of-Function Variant in a Southwest American Indian Community: Association With Increased Birth Weight and Doubled Risk of Type 2 Diabetes, Diabetes, 64, 4322, 10.2337/db15-0459
Muller, 2018, Identification and functional analysis of a novel G310D variant in the insulin-like growth factor 1 receptor (IGF1R) gene associated with type 2 diabetes in American Indians, Diabetes Metab. Res. Rev., 34, e2994, 10.1002/dmrr.2994
Muller, 2015, Assessing FOXO1A as a potential susceptibility locus for type 2 diabetes and obesity in American Indians, Obesity (Silver Spring), 23, 1960, 10.1002/oby.21236
Olaiya, 2019, Use of graded Semmes Weinstein monofilament testing for ascertaining peripheral neuropathy in people with and without diabetes, Diabetes Res. Clin. Pract., 151, 1, 10.1016/j.diabres.2019.03.029
Knowler, 1979, Islet cell antibodies and diabetes mellitus in Pima Indians, Diabetologia, 17, 161, 10.1007/BF01219743
Savage, 1979, High prevalence of diabetes in young Pima Indians: evidence of phenotypic variation in a genetically isolated population, Diabetes, 28, 937, 10.2337/diab.28.10.937
Dabelea, 1998, Increasing prevalence of Type II diabetes in American Indian children, Diabetologia, 41, 904, 10.1007/s001250051006
Katzeff, 1985, C-peptide measurement in the differentiation of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus, Diabetologia, 28, 264, 10.1007/BF00271682
Dewey, 2016, Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study, Science, 354, aaf6814, 10.1126/science.aaf6814
Assimes, 2016, Genetics of Coronary Artery Disease in Taiwan: A Cardiometabochip Study by the Taichi Consortium, PLoS ONE, 11, e0138014, 10.1371/journal.pone.0138014
Montasser, 2019, Genetic and functional evidence relates a missense variant in B4GALT1 to lower LDL-C and fibrinogen, bioRxiv
Cingolani, 2012, A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3, Fly (Austin), 6, 80, 10.4161/fly.19695
Sherry, 1999, dbSNP-database for single nucleotide polymorphisms and other classes of minor genetic variation, Genome Res., 9, 677, 10.1101/gr.9.8.677
Karczewski, 2019, Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes, bioRxiv
Auton, 2015, A global reference for human genetic variation, Nature, 526, 68, 10.1038/nature15393
Chang, 2015, Second-generation PLINK: rising to the challenge of larger and richer datasets, Gigascience, 4, 7, 10.1186/s13742-015-0047-8
Yengo, 2018, Meta-analysis of genome-wide association studies for height and body mass index in :700000 individuals of European ancestry, Hum. Mol. Genet., 27, 3641, 10.1093/hmg/ddy271
Mahajan, 2018, Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps, Nat. Genet., 50, 1505, 10.1038/s41588-018-0241-6
Liu, 2017, Exome-wide association study of plasma lipids in >300,000 individuals, Nat. Genet., 49, 1758, 10.1038/ng.3977
Yang, 2011, GCTA: a tool for genome-wide complex trait analysis, Am. J. Hum. Genet., 88, 76, 10.1016/j.ajhg.2010.11.011
Bycroft, 2018, The UK Biobank resource with deep phenotyping and genomic data, Nature, 562, 203, 10.1038/s41586-018-0579-z
Kumar, 2009, Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm, Nat. Protoc., 4, 1073, 10.1038/nprot.2009.86
Chun, 2009, Identification of deleterious mutations within three human genomes, Genome Res., 19, 1553, 10.1101/gr.092619.109
Schwarz, 2014, MutationTaster2: mutation prediction for the deep-sequencing age, Nat. Methods, 11, 361, 10.1038/nmeth.2890
Adzhubei, 2010, A method and server for predicting damaging missense mutations, Nat. Methods, 7, 248, 10.1038/nmeth0410-248
Purcell, 2014, A polygenic burden of rare disruptive mutations in schizophrenia, Nature, 506, 185, 10.1038/nature12975
Zhou, 2018, Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies, Nat. Genet., 50, 1335, 10.1038/s41588-018-0184-y
Loh, 2015, Efficient Bayesian mixed-model analysis increases association power in large cohorts, Nat. Genet., 47, 284, 10.1038/ng.3190
Farese, 1995, Knockout of the mouse apolipoprotein B gene results in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolemia in heterozygotes, Proc. Natl. Acad. Sci. USA, 92, 1774, 10.1073/pnas.92.5.1774
Raal, 2010, Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial, Lancet, 375, 998, 10.1016/S0140-6736(10)60284-X
Zhang, 1992, Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E, Science, 258, 468, 10.1126/science.1411543
Ghiselli, 1981, Type III hyperlipoproteinemia associated with apolipoprotein E deficiency, Science, 214, 1239, 10.1126/science.6795720
Rashid, 2005, Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9, Proc. Natl. Acad. Sci. USA, 102, 5374, 10.1073/pnas.0501652102
Schwartz, 2018, Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome, N. Engl. J. Med., 379, 2097, 10.1056/NEJMoa1801174
Smagris, 2016, Inactivation of Tm6sf2, a Gene Defective in Fatty Liver Disease, Impairs Lipidation but Not Secretion of Very Low Density Lipoproteins, J. Biol. Chem., 291, 10659, 10.1074/jbc.M116.719955
Homanics, 1995, Mild dyslipidemia in mice following targeted inactivation of the hepatic lipase gene, J. Biol. Chem., 270, 2974, 10.1074/jbc.270.7.2974
Khetarpal, 2017, A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels, Nat. Med., 23, 1086, 10.1038/nm.4390
Hammond, 2002, Mitochondrial glycerol-3-phosphate acyltransferase-deficient mice have reduced weight and liver triacylglycerol content and altered glycerolipid fatty acid composition, Mol. Cell. Biol., 22, 8204, 10.1128/MCB.22.23.8204-8214.2002
Béréziat, 2002, Inhibition of insulin receptor catalytic activity by the molecular adapter Grb14, J. Biol. Chem., 277, 4845, 10.1074/jbc.M106574200
Cooney, 2004, Improved glucose homeostasis and enhanced insulin signalling in Grb14-deficient mice, EMBO J., 23, 582, 10.1038/sj.emboj.7600082
Yao, 1991, Expression of carboxyl-terminally truncated forms of human apolipoprotein B in rat hepatoma cells. Evidence that the length of apolipoprotein B has a major effect on the buoyant density of the secreted lipoproteins, J. Biol. Chem., 266, 3300, 10.1016/S0021-9258(18)49988-7
Peloso, 2019, Rare Protein-Truncating Variants in APOB, Lower Low-Density Lipoprotein Cholesterol, and Protection Against Coronary Heart Disease, Circ. Genom. Precis Med., 12, e002376, 10.1161/CIRCGEN.118.002376
Morrow, 2000, Effect of arginine 172 on the binding of apolipoprotein E to the low density lipoprotein receptor, J. Biol. Chem., 275, 2576, 10.1074/jbc.275.4.2576
Zhao, 2006, Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote, Am. J. Hum. Genet., 79, 514, 10.1086/507488
Igal, 2001, Mitochondrial glycerol phosphate acyltransferase directs the incorporation of exogenous fatty acids into triacylglycerol, J. Biol. Chem., 276, 42205, 10.1074/jbc.M103386200
Rajakumar, 2009, Carnitine palmitoyltransferase IA polymorphism P479L is common in Greenland Inuit and is associated with elevated plasma apolipoprotein A-I, J. Lipid Res., 50, 1223, 10.1194/jlr.P900001-JLR200
Lemas, 2012, Genetic polymorphisms in carnitine palmitoyltransferase 1A gene are associated with variation in body composition and fasting lipid traits in Yup’ik Eskimos, J. Lipid Res., 53, 175, 10.1194/jlr.P018952
Skotte, 2017, CPT1A Missense Mutation Associated With Fatty Acid Metabolism and Reduced Height in Greenlanders, Circ Cardiovasc Genet, 10, e001618, 10.1161/CIRCGENETICS.116.001618
Brown, 2001, Molecular characterization of L-CPT I deficiency in six patients: insights into function of the native enzyme, J. Lipid Res., 42, 1134, 10.1016/S0022-2275(20)31604-7
Popineau, 2016, Novel Grb14-Mediated Cross Talk between Insulin and p62/Nrf2 Pathways Regulates Liver Lipogenesis and Selective Insulin Resistance, Mol. Cell. Biol., 36, 2168, 10.1128/MCB.00170-16
Tontonoz, 2003, Liver X receptor signaling pathways in cardiovascular disease, Mol. Endocrinol., 17, 985, 10.1210/me.2003-0061